Loading clinical trials...
Loading clinical trials...
A Double-blind, Randomized, Placebo-controlled Safety and Pharmacokinetic Study in Healthy HIV-negative Women to Assess the Delivery of Dapivirine From Matrix and Reservoir Intravaginal Rings Each Containing 25 mg of Dapivirine
Conditions
Interventions
dapivirine reservoir intravaginal ring
dapivirine matrix intravaginal ring
+1 more
Locations
1
Belgium
Drug Research Unit Ghent (D.R.U.G.)
Ghent, Belgium
Start Date
May 1, 2007
Completion Date
August 1, 2007
Last Updated
September 1, 2009
NCT04142047
NCT06694805
NCT07428330
NCT07225530
NCT05897099
NCT06665646
Lead Sponsor
International Partnership for Microbicides, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions